User profiles for Anna M. Karydas
Anna M KarydasUniversity of California, San Francisco Verified email at ucsf.edu Cited by 28673 |
Clinicopathological correlations in corticobasal degeneration
…, JY Jang, M Sidhu, TM See, AM Karydas… - Annals of …, 2011 - Wiley Online Library
Objective: To characterize cognitive and behavioral features, physical findings, and brain
atrophy patterns in pathology‐proven corticobasal degeneration (CBD) and corticobasal …
atrophy patterns in pathology‐proven corticobasal degeneration (CBD) and corticobasal …
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
…, JR Sims, H Zetterberg, K Blennow, AM Karydas… - Nature medicine, 2020 - nature.com
With the potential development of new disease-modifying Alzheimer’s disease (AD) therapies,
simple, widely available screening tests are needed to identify which individuals, who are …
simple, widely available screening tests are needed to identify which individuals, who are …
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
…, DE Barnes, M Mantle, AM Karydas… - Annals of …, 2016 - Wiley Online Library
Objective Seizures are more frequent in patients with Alzheimer's disease (AD) and can hasten
cognitive decline. However, the incidence of subclinical epileptiform activity in AD and its …
cognitive decline. However, the incidence of subclinical epileptiform activity in AD and its …
Frontotemporal dementia and its subtypes: a genome-wide association study
…, JE Parisi, WW Seeley, BL Miller, AM Karydas… - The Lancet …, 2014 - thelancet.com
Background Frontotemporal dementia (FTD) is a complex disorder characterised by a broad
range of clinical manifestations, differential pathological signatures, and genetic variability. …
range of clinical manifestations, differential pathological signatures, and genetic variability. …
[HTML][HTML] Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease
Synaptic dysfunction occurs early in senile dementias, presumably as a result of decreased
levels of functional synaptic proteins as found in autopsied brains of patients with Alzheimer’…
levels of functional synaptic proteins as found in autopsied brains of patients with Alzheimer’…
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases
…, R Sears, JR Lane, AM Karydas… - Human molecular …, 2012 - academic.oup.com
Rare mutations in the gene encoding for tau (MAPT, microtubule-associated protein tau)
cause frontotemporal dementia-spectrum (FTD-s) disorders, including FTD, progressive …
cause frontotemporal dementia-spectrum (FTD-s) disorders, including FTD, progressive …
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→ T (Arg493X) mutation: an international initiative
Background The progranulin gene (GRN) is mutated in 5–10% of patients with frontotemporal
lobar degeneration (FTLD) and in about 20% of patients with familial FTLD. The most …
lobar degeneration (FTLD) and in about 20% of patients with familial FTLD. The most …
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion
…, NJ Rutherford, JC Fong, AM Karydas… - Journal of Neurology …, 2012 - jnnp.bmj.com
Background Some patients meeting behavioural variant frontotemporal dementia (bvFTD)
diagnostic criteria progress slowly and plateau at mild symptom severity. Such patients have …
diagnostic criteria progress slowly and plateau at mild symptom severity. Such patients have …
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
Co-pathologies play an important role in the expression of the Alzheimer’s disease clinical
phenotype and may influence treatment efficacy. Early-onset Alzheimer’s disease, defined as …
phenotype and may influence treatment efficacy. Early-onset Alzheimer’s disease, defined as …
Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion
…, AM Karydas, NR Block, G Coppola, M Pribadi… - Brain, 2014 - academic.oup.com
Hexanucleotide repeat expansion in C9orf72 represents the most common genetic cause of
familial and sporadic behavioural variant frontotemporal dementia. Previous studies show …
familial and sporadic behavioural variant frontotemporal dementia. Previous studies show …